Loading
PB
Principia Biopharma Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Becker Daniel J., was filed 22 Nov 2019.
Principia Biopharma Inc.: what insiders have been doing
Every trade that managers of Principia Biopharma Inc. disclose to SEC (Form 4) is tracked on this page. Principia Biopharma Inc. has had no insider filing for more than a year; the last one goes back to 28 September 2020.
Looking back to 2018, when coverage begins, insiders filed 8 purchases and 58 sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
148
Thresholds
n/a
Buy Volume
€36M
8 ops. · all time
Sell Volume
€48M
58 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
Revenue31.3M
Net income16.2M51.7% margin
Last declaration on 28 September 2020
Declarations148 total
117,761 shares@ US$100.0089.8% of flowCommon StockSEC:0001209191-20-052225:0
1,916 shares@ US$100.001.5% of flowCommon StockSEC:0001209191-20-052225:1
2,982,855 shares@ US$100.00100.0% of flowCommon StockSEC:0001209191-20-052233:0
3,799 shares@ US$100.0015.0% of flowCommon StockSEC:0001209191-20-052224:0
3,302 shares@ US$100.0013.0% of flowCommon StockSEC:0001209191-20-052224:1
2,207 shares@ US$100.006.1% of flowCommon StockSEC:0001209191-20-052226:0
13,592 shares@ US$100.0053.4% of flowCommon StockSEC:0001209191-20-052227:1
31,826 shares@ US$100.0076.9% of flowCommon StockSEC:0001209191-20-052223:0
667,600 shares@ US$100.00100.0% of flowCommon StockSEC:0001209191-20-052229:0
1,023 shares@ US$100.001.3% of flowCommon StockSEC:0001209191-20-052222:0
39,179 shares@ US$100.0049.9% of flowCommon StockSEC:0001209191-20-052222:1
18,355 shares@ US$100.0023.4% of flowCommon StockSEC:0001209191-20-052222:2
5,504 shares0Common StockSEC:0001209191-20-052227:0
2,758 shares@ US$4.720.1% of flowCommon StockSEC:0001209191-20-051590:0
2,242 shares@ US$7.270.1% of flowCommon StockSEC:0001209191-20-051590:1
5,000 shares@ US$99.983.8% of flowCommon StockSEC:0001209191-20-051590:2
7,500 shares@ US$3.000.9% of flowCommon StockSEC:0001209191-20-047832:0
7,500 shares@ US$99.3728.7% of flowCommon StockSEC:0001209191-20-047832:1
15,000 shares@ US$23.779.6% of flowCommon StockSEC:0001209191-20-047842:0
15,000 shares@ US$100.0040.4% of flowCommon StockSEC:0001209191-20-047842:1
2,447 shares@ US$3.000.2% of flowCommon StockSEC:0001209191-20-046484:0
3,553 shares@ US$3.180.3% of flowCommon StockSEC:0001209191-20-046484:1
858 shares@ US$86.111.8% of flowCommon StockSEC:0001209191-20-046484:2
700 shares@ US$86.921.5% of flowCommon StockSEC:0001209191-20-046484:3
2,534 shares@ US$88.405.4% of flowCommon StockSEC:0001209191-20-046484:4
25 of 148 declarations
About Principia Biopharma Inc.
Principia Biopharma Inc. is a biopharmaceutical company focused on developing treatments for autoimmune diseases. It is listed on the NASDAQ under the ticker symbol PRNB.
